scholarly journals CELL STORAGE-01-Freezing and Thawing Protocol for Adherent Cell Lines v1

protocols.io ◽  
2021 ◽  
Author(s):  
Marco Cosentino ◽  
Alessandra Luini ◽  
Massimiliano Legnaro ◽  
Emanuela Rasini ◽  
Mariagiulia Albizzati ◽  
...  
protocols.io ◽  
2021 ◽  
Author(s):  
Marco Cosentino ◽  
Alessandra Luini ◽  
Massimiliano Legnaro ◽  
Emanuela Rasini ◽  
Mariagiulia Albizzati ◽  
...  

protocols.io ◽  
2020 ◽  
Author(s):  
Lucy Kimbley ◽  
Rachel Parker ◽  
Maaike Sybil ◽  
John Holloway ◽  
Emily Swindle ◽  
...  

Blood ◽  
1996 ◽  
Vol 88 (9) ◽  
pp. 3465-3473 ◽  
Author(s):  
KM Hudson ◽  
NC Denko ◽  
E Schwab ◽  
E Oswald ◽  
A Weiss ◽  
...  

Cytotoxic necrotizing factor (CNF) toxins, isolated from certain Escherichia coli strains known to cause intestinal and extra intestinal infections, induce reorganization of the actin cytoskeleton and generate hyperploidy in adherent cell lines. We have examined the effect of CNF toxin on one of the few cell types that naturally increase nuclear DNA content, megakaryocytes. Our studies show that only hematopoietic cells capable of differentiating along the megakaryocyte lineage responded to the CNF2 toxin by becoming polyploid and by reorganizing actin. The K562, HEL, and CHRF-288–11 cell lines can be induced with phorbol ester to differentiate along the megakaryocyte lineage, and these cells also respond to the toxin with increased DNA content and actin cytoskeletal rearrangements. Interestingly, treatment of the K562 and HEL cell lines with CNF2 does not result in an increase in production of the megakaryocytic marker glycoprotein IIIa, unlike phorbol ester treatment. Conversely, two T-cell leukemic cell lines, CEM and Molt4, and the promyelocytic HL-60 cell line, which do not differentiate along the megakaryocyte lineage in response to phorbol myristate acetate, do not respond to CNF2, by increased expression of gpIIIa, increased nuclear DNA content, or actin reorganization. A potential target of these toxins, RhoA, is expressed by both megakaryocytic and nonmegakaryocytic cell lines, as shown by reverse transcription-polymerase chain reaction and Western blot. Although it is clear that the CNF toxins can affect a wide variety of adherent nonhematopoietic cell lines, we propose that the response to CNF, in terms of reorganizing actin structure and increase in DNA content in hematologic suspension cells, correlates with the capability of these target cells to differentiate along the megakaryocytic lineage.


Blood ◽  
2004 ◽  
Vol 104 (9) ◽  
pp. 2873-2878 ◽  
Author(s):  
Nisha Shah ◽  
Rebecca J. Asch ◽  
Alana S. Lysholm ◽  
Tucker W. LeBien

Abstract We have established human B-lineage (BLIN) acute lymphoblastic leukemia cell lines that retain a dependency on fibroblast monolayers for survival and proliferation. Eight hours following removal from adherent cell contact BLIN cells undergo a decrease in mitochondrial transmembrane potential and an increase in annexin V binding. Unexpectedly, the caspase-9 inhibitor (C9i) benzyloxycarbonyl-Leu-Glu-His-Asp-fluoromethylketone enhanced the appearance of apoptotic cells within 8 hours following removal of BLIN cells from fibroblast monolayers. C9i enhancement of apoptosis was dose dependent and did not occur with irreversible inhibitors of caspases-2, -3, -6, and -8. C9i also enhanced apoptosis in cord blood-derived CD19+ B-lineage cells (but not myeloid cells) removed from murine stromal cells. Longer exposure (> 18 hours) to C9i culminated in apoptosis in a panel of B-lineage acute lymphoblastic leukemia (ALL) cell lines in the presence or absence of fibroblast monolayers, as well as in 2 proliferating leukemic cell lines (RAMOS and CEM). BLIN-4L cells made deficient in caspase-9 by RNA interference exhibited no resistance to apoptotic signals and actually showed increased apoptotic sensitivity to staurosporine. These collective results suggest that a 4-amino acid caspase inhibitor of caspase-9 can promote apoptosis and that at least some types of apoptotic pathways in B-lineage ALL do not require caspase-9.


1983 ◽  
Vol 8 (4) ◽  
pp. 161-165 ◽  
Author(s):  
Berthold G. D. Bödeker ◽  
Guy J. Berg ◽  
Guy Hewlett ◽  
H. Dieter Schlumberger
Keyword(s):  

1995 ◽  
Vol 60 (1) ◽  
pp. 100-107 ◽  
Author(s):  
J. Helen Leonard ◽  
Peter Dash ◽  
Peter Holland ◽  
John H. Kearsley ◽  
John R. Bell

2020 ◽  
Vol 83 (11) ◽  
pp. 3250-3261
Author(s):  
Csaba Bús ◽  
Ágnes Kulmány ◽  
Norbert Kúsz ◽  
Tímea Gonda ◽  
István Zupkó ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Mohamed Azarkan ◽  
Erik Maquoi ◽  
François Delbrassine ◽  
Raphael Herman ◽  
Nasiha M’Rabet ◽  
...  

Abstract The Ananascomosus stem extract is a complex mixture containing various cysteine ​​proteases of the C1A subfamily, such as bromelain and ananain. This mixture used for centuries in Chinese medicine, has several potential therapeutic applications as anti-cancer, anti-inflammatory and ecchymosis degradation agent. In the present work we determined the structures of bromelain and ananain, both in their free forms and in complex with the inhibitors E64 and TLCK. These structures combined with protease-substrate complexes modeling clearly identified the Glu68 as responsible for the high discrimination of bromelain in favor of substrates with positively charged residues at P2, and unveil the reasons for its weak inhibition by cystatins and E64. Our results with purified and fully active bromelain, ananain and papain show a strong reduction of cell proliferation with MDA-MB231 and A2058 cancer cell lines at a concentration of about 1 μM, control experiments clearly emphasizing the need for proteolytic activity. In contrast, while bromelain and ananain had a strong effect on the proliferation of the OCI-LY19 and HL-60 non-adherent cell lines, papain, the archetypal member of the C1A subfamily, had none. This indicates that, in this case, sequence/structure identity beyond the active site of bromelain and ananain is more important than substrate specificity.


1997 ◽  
Vol 110 (19) ◽  
pp. 2441-2447 ◽  
Author(s):  
A. Subtil ◽  
A. Dautry-Varsat

The microtubule cytoskeleton is generally not considered to be essential for the first steps of clathrin-mediated endocytosis of membrane receptors. Its role in clathrin-independent endocytosis has not been investigated. We have previously shown that the cytokine interleukin 2 (IL2) is internalized in lymphoid cells expressing its receptors when clathrin-dependent endocytosis is inhibited. Here we compare the internalization of IL2 and of transferrin, a marker of clathrin-dependent endocytosis, after microtubule disruption. In hemopoietic cell lines, which express IL2 receptors, transferrin receptor entry was inhibited by about 40%. However, in adherent cell lines, transferrin entry was unaffected by microtubule disruption, as previously reported. Unlike the case for transferrin, internalization of IL2 receptors was not affected by depolymerization of the microtubule cytoskeleton in hemopoietic cell lines. These results show that IL2 and transferrin receptors do not have the same endocytic properties and support our previous conclusion that these receptors follow different pathways of endocytosis.


RSC Advances ◽  
2014 ◽  
Vol 4 (65) ◽  
pp. 34443-34447 ◽  
Author(s):  
Lei Li ◽  
Xiaoqing Lv ◽  
Hua Guo ◽  
Xuetao Shi ◽  
Jing Liu

This paper describes a simple protocol for directly freezing and thawing mammalian cells on a PDMS–glass chip, which enables cell storage on chip at −80 °C for several days to several months.


Sign in / Sign up

Export Citation Format

Share Document